Literature DB >> 2294240

Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts.

J R Spencer1, A G Brodin, J M Ignatoff.   

Abstract

We report a case of clear cell adenocarcinoma arising in a paraurethral duct treated by anterior pelvic exenteration. Immunohistochemical stains for prostate specific acid phosphatase and prostate specific antigen were positive in the primary tumor and regional metastases. Focal positive staining also was noted in normal paraurethral duct epithelium. Our observations suggest that clear cell adenocarcinoma arises from the female paraurethral ducts, rather than embryonic remnants. These ducts appear to be homologous to the prostate and in some cases may be misinterpreted as urethral diverticula.

Entities:  

Mesh:

Year:  1990        PMID: 2294240     DOI: 10.1016/s0022-5347(17)39887-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Advanced clear-cell adenocarcinoma of the bladder successfully treated by radical surgery with adjuvant chemoradiotherapy.

Authors:  Shinji Kurosaka; Akira Irie; Hideyuki Mizoguchi; Norihiko Okuno; Keiichi Iwabuchi; Shiro Baba
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

2.  Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing.

Authors:  Rohit Mehra; Pankaj Vats; Shanker Kalyana-Sundaram; Aaron M Udager; Michael Roh; Ajjai Alva; Jincheng Pan; Robert J Lonigro; Javed Siddiqui; Alon Weizer; Cheryl Lee; Xuhong Cao; Yi-Mi Wu; Dan R Robinson; Saravana M Dhanasekaran; Arul M Chinnaiyan
Journal:  Am J Pathol       Date:  2014-01-03       Impact factor: 4.307

3.  Female urethral syndrome. A female prostatitis?

Authors:  R F Gittes; R M Nakamura
Journal:  West J Med       Date:  1996-05

4.  Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems.

Authors:  Borislav A Alexiev; Fabio Tavora
Journal:  Virchows Arch       Date:  2013-01-11       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.